We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
Cap. Flow
+$423M
Cap. Flow %
5.97%
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$188M
2
LH icon
Labcorp
LH
+$183M
3
AGN
Allergan Inc
AGN
+$144M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$93.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$82.2M

Top Sells

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$104M
2
CAH icon
Cardinal Health
CAH
+$104M
3
AGN
Allergan plc
AGN
+$80.7M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$60.3M
5
ELV icon
Elevance Health
ELV
+$55.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.3%
2 Consumer Discretionary 5.38%
3 Financials 4.49%
4 Industrials 3.37%
5 Technology 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MED icon
26
Medifast
MED
$107M
$45.3M 0.64%
1,350,000
– –
AGN
27
PUT
DELISTED
Allergan Inc
AGN
$45.2M 0.64%
212,700
+211,755
+22,408% +$42.1M
ACOR
28
DELISTED
Acorda Therapeutics
ACOR
$43.1M 0.61%
8,786
+4,369
+99% +$18.7M
HUM icon
29
Humana
HUM
$43.9B
$42.2M 0.6%
+293,702
New +$40.1M
MDT icon
30
Medtronic
MDT
$112B
$40.3M 0.57%
558,642
-40,988
-7% -$2.85M
BDX icon
31
Becton Dickinson
BDX
$46.4B
$36.3M 0.51%
267,393
+255,708
+2,188% +$32.7M
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
$35.8M 0.51%
1,333,031
-1,692,381
-56% -$49.5M
XL
33
DELISTED
XL Group Ltd.
XL
$35.3M 0.5%
1,028,101
+190,257
+23% +$6.49M
FWONA icon
34
Liberty Media Series A
FWONA
$23.4B
$34.3M 0.48%
1,446,174
-197,912
-12% -$4.67M
RARE icon
35
Ultragenyx Pharmaceutical
RARE
$2.46B
$33.5M 0.47%
763,402
+186,867
+32% +$8.56M
GRFS
36
Grifois
GRFS
$5.55B
$33.3M 0.47%
1,956,770
-301,498
-13% -$5.19M
AAL icon
37
American Airlines Group
AAL
$9.82B
$33.2M 0.47%
619,078
+433,668
+234% +$18.7M
SKX
38
DELISTED
Skechers
SKX
$33M 0.47%
1,793,334
+633,153
+55% +$11.8M
ELOS
39
DELISTED
Syneron Medical Ltd
ELOS
$31.8M 0.45%
3,410,000
– –
RNA
40
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$31.1M 0.44%
+1,656,698
New +$23.5M
TWC
41
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$30.3M 0.43%
199,242
+30,282
+18% +$4.37M
QTNT
42
DELISTED
Quotient Limited Ordinary Shares
QTNT
$29.6M 0.42%
41,129
+32,939
+402% +$15.6M
ALGN icon
43
Align Technology
ALGN
$12.9B
$29.4M 0.42%
525,953
+522,060
+13,410% +$27.6M
SJNK icon
44
CALL
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.87B
$28.9M 0.41%
+1,000,000
New +$29.5M
NEE icon
45
NextEra Energy
NEE
$184B
$28.6M 0.4%
1,076,764
+345,520
+47% +$8.72M
CBPO
46
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$27.2M 0.38%
404,868
-2,493
-0.6% -$154K
KANG
47
DELISTED
iKang Healthcare Group, Inc.
KANG
$26.9M 0.38%
1,785,351
+788,738
+79% +$14M
FEIC
48
DELISTED
FEI COMPANY
FEIC
$25M 0.35%
276,498
+247,134
+842% +$20.6M
SIEN
49
DELISTED
Sientra, Inc.
SIEN
$24.8M 0.35%
+147,500
New +$25.2M
ROC
50
DELISTED
ROCKWOOD HLDGS INC
ROC
$24.6M 0.35%
312,172
+258,851
+485% +$20M
1
2
3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.

  • Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
  • Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
  • Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
  • Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
  • Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
  • Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
  • Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.